Skip to main content
Skip to main content
TYNE logo

Direxion Nanotechnology ETF (TYNE) Stock Analysis

$17.26 +$0.00 (+0.00%) |CouncilBearish Lean · 28 · F
Direxion Nanotechnology ETF (TYNE) bottom line: signals are mixed — the Council read leans Bearish Lean (28/100) while the AI fundamental score is 0/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $1.32M| Vol: 172|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Direxion Nanotechnology ETF (TYNE) trades at $17.26. Direxion Nanotechnology ETF (TYNE) aims to replicate the performance of the S&P Nanotechnology Index, investing primarily in U. S. -listed companies involved in the nanotechnology industry. Market cap: $1.32M, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026
Direxion Nanotechnology ETF (TYNE) aims to replicate the performance of the S&P Nanotechnology Index, investing primarily in U.S.-listed companies involved in the nanotechnology industry. As a non-diversified fund, TYNE focuses its investments, potentially leading to higher volatility.

Analyst Coverage for TYNE: TYNE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TYNE against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the TYNE film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 28/100 · F

TYNE: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Direxion Nanotechnology ETF (TYNE) Financial Services Profile

IPO Year2021

Direxion Nanotechnology ETF (TYNE) is a non-diversified fund seeking to mirror the S&P Nanotechnology Index, targeting U.S.-listed firms in the nanotechnology sector. It offers investors focused exposure to this emerging technology, but its concentrated portfolio may result in greater price fluctuations compared to diversified ETFs.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for TYNE?

As of Mar 18, 2026 — figures reflect the data available on that date.

Direxion Nanotechnology ETF (TYNE) presents a focused investment in the nanotechnology sector, aligning with the S&P Nanotechnology Index. Key value drivers include the growth of the nanotechnology market, projected to reach significant expansion by 2030, and the increasing integration of nanotechnology across diverse industries. The ETF's non-diversified nature amplifies both potential gains and losses, making it suitable for investors with a high-risk tolerance seeking targeted exposure to this innovative field. Ongoing advancements in materials science and biomedical applications serve as potential catalysts, while regulatory changes and technological disruptions pose potential risks. Investors should monitor the performance of the underlying index and the financial health of the constituent companies.

Based on FMP financials and quantitative analysis

TYNE Key Highlights

TYNE is a non-diversified fund, concentrating its investments in the nanotechnology sector.

  • The fund aims to replicate the performance of the S&P Nanotechnology Index.
  • The ETF provides exposure to U.S.-listed companies, including depositary receipts, involved in nanotechnology.
  • TYNE's performance is closely tied to the growth and innovation within the nanotechnology industry.
  • The fund's concentrated portfolio may lead to higher volatility compared to diversified ETFs.

Who Are TYNE's Competitors?

TYNE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ALISR Calisa Acquisition Corp Right $0.64 +0.00% 79
IDKFF ThreeD Capital Inc. $0.07 +13.85% $6.98M 70
ALTEX Firsthand Alternative Energy Fund $12.93 -1.90% $8.98M 82
BCG Binah Capital Group, Inc. $1.40 +0.72% $23.5M 78
EEA The European Equity Fund, Inc. $11.15 -0.59% $74.7M 67
HNNA Hennessy Advisors, Inc. $9.89 -1.30% $78.2M 81
ETHT ProShares - Ultra Ether ETF $12.57 +19.94% $92.2M 68
TPZ Tortoise Electrification Infrastructure ETF $21.62 -0.18% $127M 70

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TYNE's Key Strengths?

Focused exposure to the high-growth nanotechnology sector.

  • Established tracking of the S&P Nanotechnology Index.
  • Potential for high returns due to the non-diversified nature.
  • Liquid and easily accessible through ETF structure.

What Are TYNE's Weaknesses?

Non-diversified portfolio increases risk and volatility.

  • Performance is highly dependent on the nanotechnology sector.
  • Subject to regulatory and technological risks.
  • Management fees can impact overall returns.

What Could Drive TYNE Stock Higher?

Increasing adoption of nanotechnology in healthcare, electronics, and energy.

  • Government and private sector investments in nanotechnology research and development.
  • Potential breakthroughs in nanotechnology applications and commercialization.
  • Growing demand for nanotechnology-enabled products and services.

What Are the Key Risks for TYNE?

Technological obsolescence and disruption in the nanotechnology sector.

  • Regulatory changes and compliance costs impacting nanotechnology companies.
  • Market volatility and economic downturns affecting investment returns.
  • Competition from other nanotechnology ETFs and investment products.
  • Non-diversified portfolio increases risk and volatility.

What Are the Growth Opportunities for TYNE?

  • Expansion of Nanotechnology Applications in Healthcare: The increasing use of nanotechnology in drug delivery, diagnostics, and regenerative medicine presents a significant growth opportunity for TYNE. The global nanomedicine market is projected to reach $376.47 billion by 2030, driven by advancements in targeted therapies and personalized medicine. Companies within TYNE's portfolio stand to benefit from this trend, potentially boosting the ETF's performance. This growth is contingent on regulatory approvals and successful clinical trials.
  • Integration of Nanomaterials in Electronics: Nanotechnology is playing a crucial role in enhancing the performance and efficiency of electronic devices. The market for nanomaterials in electronics is expected to grow as manufacturers seek to develop smaller, faster, and more energy-efficient products. TYNE's exposure to companies involved in the production and application of nanomaterials in electronics positions it to capitalize on this growth. The timeline for this growth is dependent on technological breakthroughs and market adoption rates.
  • Advancements in Nanotechnology for Energy Storage: Nanotechnology is being used to develop advanced energy storage solutions, such as high-capacity batteries and fuel cells. The demand for these technologies is increasing due to the growing adoption of electric vehicles and renewable energy sources. TYNE's investments in companies developing nanotechnology-based energy storage solutions could drive growth. The market for nanotechnology in energy storage is projected to expand significantly over the next decade, driven by government incentives and technological advancements.
  • Development of Nanotechnology-Enabled Environmental Solutions: Nanotechnology is being applied to address environmental challenges, such as water purification and pollution control. The market for nanotechnology-enabled environmental solutions is growing as governments and industries seek sustainable technologies. TYNE's exposure to companies developing these solutions could provide a growth opportunity. The timeline for this growth is dependent on regulatory mandates and the adoption of sustainable practices.
  • Increasing Investment in Nanotechnology Research and Development: Governments and private companies are investing heavily in nanotechnology research and development, driving innovation and commercialization. This investment is expected to fuel the growth of the nanotechnology sector and benefit companies within TYNE's portfolio. The global investment in nanotechnology R&D is projected to increase, creating opportunities for companies to develop and market new nanotechnology-based products and services. This ongoing investment supports long-term growth prospects for the ETF.

What Are TYNE's Competitive Advantages?

  • Established tracking of the S&P Nanotechnology Index.
  • Specialized focus on the nanotechnology sector.
  • Brand recognition as a Direxion ETF.
  • Access to a portfolio of nanotechnology-related companies.

What Does TYNE Do?

The Direxion Nanotechnology ETF (TYNE) is designed to provide investors with exposure to companies involved in the nanotechnology industry. The fund operates by investing at least 80% of its assets in securities that comprise the S&P Nanotechnology Index or in investments that exhibit similar economic characteristics. This index, maintained by S&P Dow Jones Indices LLC, tracks the performance of U.S.-listed companies, including depositary receipts, that are significantly engaged in nanotechnology. Nanotechnology involves the manipulation of matter on an atomic and molecular scale, with applications spanning various sectors, including medicine, electronics, and materials science. TYNE is a non-diversified fund, meaning it concentrates its investments in a smaller number of holdings compared to diversified ETFs. This concentration can lead to higher potential returns but also increased risk due to the fund's sensitivity to the performance of a limited number of companies. The fund's investment strategy focuses on replicating the index's composition, aiming to deliver returns that closely match the index's performance. As an ETF, TYNE offers investors the flexibility to buy and sell shares throughout the trading day, providing liquidity and ease of access to the nanotechnology sector.

What Products and Services Does TYNE Offer?

  • Invests in U.S.-listed companies involved in the nanotechnology industry.
  • Seeks to replicate the performance of the S&P Nanotechnology Index.
  • Provides investors with exposure to the nanotechnology sector.
  • Offers a non-diversified investment approach.
  • Tracks companies engaged in the manipulation of matter at the atomic and molecular scale.
  • Focuses on companies developing nanotechnology applications across various sectors.

How Does TYNE Make Money?

  • Generates revenue through management fees charged to investors.
  • Aims to provide investment returns that mirror the S&P Nanotechnology Index.
  • Manages a portfolio of stocks in nanotechnology-related companies.
  • Offers a passively managed investment strategy.

What Industry Does TYNE Operate In?

The asset management industry is undergoing significant transformation, driven by technological advancements, regulatory changes, and evolving investor preferences. ETFs like TYNE offer targeted exposure to specific sectors, catering to investors seeking specialized investment strategies. The nanotechnology sector itself is experiencing rapid growth, with applications in medicine, electronics, and materials science. Competition among asset managers is intense, with firms vying to offer innovative and cost-effective investment products. TYNE's success depends on its ability to accurately track its benchmark index and attract investors interested in the nanotechnology space.

Who Are TYNE's Key Customers?

  • Individual investors seeking exposure to the nanotechnology sector.
  • Institutional investors looking for targeted investment strategies.
  • Financial advisors seeking specialized investment products for their clients.
  • Investors with a high-risk tolerance seeking potential high returns.
AI Confidence: 71% Updated: Mar 18, 2026

TYNE Valuation & Market Position

With a $1.32M market cap, Direxion Nanotechnology ETF sits in the micro-cap segment of the market.

ROE 0%

Key Financial Metrics

Return on equity for Direxion Nanotechnology ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. TYNE trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

TYNE Financials

Bull Case vs Bear Case

Bull Case

  • Focused exposure to the high-growth nanotechnology sector.
  • Established tracking of the S&P Nanotechnology Index.
  • Potential for high returns due to the non-diversified nature.
  • Liquid and easily accessible through ETF structure.

Bear Case

  • Non-diversified portfolio increases risk and volatility.
  • Performance is highly dependent on the nanotechnology sector.
  • Subject to regulatory and technological risks.
  • Management fees can impact overall returns.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

TYNE Latest News

No recent news available for TYNE.

TYNE Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TYNE.

Price Targets

Wall Street price target analysis for TYNE.

TYNE MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates TYNE 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Common Questions About TYNE (Financial Services)

What does Direxion Nanotechnology ETF do?

Direxion Nanotechnology ETF (TYNE) is designed to track the performance of the S&P Nanotechnology Index, providing investors with targeted exposure to companies involved in the nanotechnology industry. The fund invests at least 80% of its assets in the securities that comprise the index, focusing on U.S.-listed companies, including depositary receipts.

What are the main risks for TYNE?

The main risks for Direxion Nanotechnology ETF (TYNE) include its non-diversified portfolio, which increases volatility and sensitivity to the performance of a limited number of companies. Technological obsolescence and disruption in the nanotechnology sector pose a risk to the fund's investments. Regulatory changes and compliance costs could also impact the profitability of nanotechnology companies.

What are the key factors to evaluate for TYNE?

Evaluate TYNE on fundamentals, analyst consensus, and risk factors. Direxion Nanotechnology ETF (TYNE) presents a focused investment in the nanotechnology sector, aligning with the S&P Nanotechnology Index. Not financial advice.

How frequently does TYNE data refresh on this page?

TYNE's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven TYNE's recent stock price performance?

Direxion Nanotechnology ETF (TYNE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused exposure to the high-growth nanotechnology sector. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TYNE overvalued or undervalued right now?

Direxion Nanotechnology ETF (TYNE) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research TYNE before investing?

Before investing in Direxion Nanotechnology ETF (TYNE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding TYNE to a portfolio?

Key strength of Direxion Nanotechnology ETF (TYNE): Focused exposure to the high-growth nanotechnology sector. Weigh rewards against risks and diversify. Not financial advice.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and may be subject to change.
  • AI analysis is pending for TYNE, which may provide additional insights.
Data Sources

Popular Stocks

More Stocks We Cover